Zobrazeno 1 - 10 of 37 pro vyhledávání: '"E. C. Wolters"'
2
Detection by polymerase chain reaction of Treponema pallidum DNA in cerebrospinal fluid from neurosyphilis patients before and after antibiotic treatment
Autor: M. E. J. De Jonge, E. C. Wolters, G. T. Noordhoek, J. D. A. Van Embden
Publikováno v: Journal of Clinical Microbiology. 29:1976-1984
A polymerase chain reaction with nested primer pairs based on the DNA sequence of the 39-kDa bmp gene of Treponema pallidum subsp. pallidum is described. The method allowed the detection of purified T. pallidum DNA equivalent to the amount of DNA in
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::066915c6666adf8d6babd3dfd21656de
https://doi.org/10.1128/jcm.29.9.1976-1984.1991
Zobrazit plný text záznamu
4
Psychiatric complications in Parkinson's disease
Autor: E C, Wolters
Publikováno v: Journal of neural transmission. Supplementum. (60)
Parkinson's disease (PD) is caused by an abnormal degeneration of the dopamine (DA) producing cells in the substantia nigra (SN) and ventral tegmentum area (VTA) in combination with a varying decay of the noradrenergic (locus coeruleus), cholinergic
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::33e453a4b1a9e4a46427f98cbb05a19f
https://pubmed.ncbi.nlm.nih.gov/11205148
Zobrazit plný text záznamu
5
Loss of olfaction in de novo and treated Parkinson's disease: possible implications for early diagnosis
Autor: G, Tissingh, H W, Berendse, P, Bergmans, R, DeWaard, B, Drukarch, J C, Stoof, E C, Wolters
Publikováno v: Movement disorders : official journal of the Movement Disorder Society. 16(1)
Olfactory dysfunction is a common finding in patients with Parkinson's disease (PD). As most studies reported on odor identification in more advanced and treated PD, we administered an odor detection, discrimination, and identification test to a hete
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::fd3723d7fc131314d3a81c2e6808120e
https://pubmed.ncbi.nlm.nih.gov/11215591
Zobrazit plný text záznamu
6
Imaging of dopamine transporters with [123I]FP-CIT SPECT does not suggest a significant effect of age on the symptomatic threshold of disease in Parkinson's disease
Autor: J, Booij, P, Bergmans, A, Winogrodzka, J D, Speelman, E C, Wolters
Publikováno v: Synapse (New York, N.Y.). 39(2)
Parkinson's disease (PD) is characterized neuropathologically by degeneration of the nigrostriatal dopaminergic pathway. With natural aging there is loss of dopaminergic cells in the substantia nigra and, consequently, loss of dopamine transporters i
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::de2cd7d9494482e3c0deabbe664a96de
https://pubmed.ncbi.nlm.nih.gov/11180497
Zobrazit plný text záznamu
7
Preclinical (premotor) Parkinson's disease
Autor: E C, Wolters, C, Francot, P, Bergmans, A, Winogrodzka, J, Booij, H W, Berendse, J C, Stoof
Publikováno v: Journal of neurology. 247
Parkinson's disease (PD) is an idiopathic disease caused by necrosis and apoptosis of dopaminergic cells in the brainstem, which are probably induced by oxidative stress. Current therapeutic strategies comprise symptomatic and restorative treatment.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::6dc30bc437a7ab45359beb39713cfe7d
https://pubmed.ncbi.nlm.nih.gov/10991655
Zobrazit plný text záznamu
8
Dopaminomimetic psychosis in Parkinson's disease patients: diagnosis and treatment
Autor: E C, Wolters
Publikováno v: Neurology. 52(7 Suppl 3)
Dopaminomimetic agents, which were rationally designed to reverse dopamine deficits in the substantia nigra and ventral tegmental area of the parkinsonian midbrain, effectively attenuate deficits in motor and non-motor behavior thought to be elicited
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::2393c696da5d398f6af9fe87eed1ea61
https://pubmed.ncbi.nlm.nih.gov/10227604
Zobrazit plný text záznamu
9
Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease
Autor: J, Booij, J B, Habraken, P, Bergmans, G, Tissingh, A, Winogrodzka, E C, Wolters, A G, Janssen, J C, Stoof, E A, van Royen
Publikováno v: Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 39(11)
Several SPECT studies reported decreased striatal 123I-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iodoph enyl)nortropane ([123I]FP-CIT) binding in patients with Parkinson's disease. For application in routine clinical studies, information on th
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::83d638250e1ee24f337fb82f0167da18
https://pubmed.ncbi.nlm.nih.gov/9829575
Zobrazit plný text záznamu
10
Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease
Autor: G, Tissingh, J, Booij, P, Bergmans, A, Winogrodzka, A G, Janssen, E A, van Royen, J C, Stoof, E C, Wolters
Publikováno v: Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 39(7)
The aims of this study were to investigate whether the loss of striatal dopamine transporters in early and drug-naive patients with Parkinson's disease could be demonstrated by means of 123I-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iodoph eny
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::cbf9119469d5c911415544c1e12e0ed9
https://pubmed.ncbi.nlm.nih.gov/9669384
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje